ATE86630T1 - Purin-derivate mit pharmakologischer wirksamkeit. - Google Patents

Purin-derivate mit pharmakologischer wirksamkeit.

Info

Publication number
ATE86630T1
ATE86630T1 AT89902205T AT89902205T ATE86630T1 AT E86630 T1 ATE86630 T1 AT E86630T1 AT 89902205 T AT89902205 T AT 89902205T AT 89902205 T AT89902205 T AT 89902205T AT E86630 T1 ATE86630 T1 AT E86630T1
Authority
AT
Austria
Prior art keywords
pct
pharmacological activity
purine derivatives
sec
date
Prior art date
Application number
AT89902205T
Other languages
English (en)
Inventor
Ferraris Paolo Cornaglia
Riccardo Stradi
Original Assignee
Co Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Co Pharma Corp filed Critical Co Pharma Corp
Application granted granted Critical
Publication of ATE86630T1 publication Critical patent/ATE86630T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043—Leu-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT89902205T 1987-12-24 1988-12-22 Purin-derivate mit pharmakologischer wirksamkeit. ATE86630T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT23218/87A IT1223604B (it) 1987-12-24 1987-12-24 Derivati purinici ad azione farmacologica
EP89902205A EP0346460B1 (de) 1987-12-24 1988-12-22 Purin-derivate mit pharmakologischer wirksamkeit
PCT/EP1988/001194 WO1989005818A1 (en) 1987-12-24 1988-12-22 Purine derivatives having pharmacological action

Publications (1)

Publication Number Publication Date
ATE86630T1 true ATE86630T1 (de) 1993-03-15

Family

ID=11205008

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89902205T ATE86630T1 (de) 1987-12-24 1988-12-22 Purin-derivate mit pharmakologischer wirksamkeit.

Country Status (8)

Country Link
US (1) US5110798A (de)
EP (1) EP0346460B1 (de)
JP (1) JP2868560B2 (de)
AT (1) ATE86630T1 (de)
AU (1) AU3052889A (de)
DE (1) DE3879191T2 (de)
IT (1) IT1223604B (de)
WO (1) WO1989005818A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1241452B (it) * 1990-06-28 1994-01-17 Sigma Tau Ind Farmaceuti Derivati oligopeptidici dell'ipoxantina dotati di attivita' immunomodulante e composizioni farmaceutiche che li contengono
US6110923A (en) * 1994-06-22 2000-08-29 Biochem Pharma Inc. Method for treating cancer using novel substituted purinyl derivatives with immunomodulating activity
FR2753707B1 (fr) * 1996-09-23 1998-12-11 Complexes nucleopeptidiques, compositions cosmetologiques et pharmaceutiques les contenant et utilisations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5754157A (en) * 1980-09-19 1982-03-31 Nippon Kayaku Co Ltd L-argininal derivative and its preparation
AU564576B2 (en) * 1981-09-24 1987-08-20 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Purine derivatives
DE3141923A1 (de) * 1981-10-22 1983-05-05 Kunz, Horst, Prof. Dr., 6500 Mainz 2(2-pyridyl)ethoxycarbonyl- und 2-(4-pyridyl)ethxycarbonyl-verbindungen und deren pyridiniumsalze
US4387049A (en) * 1982-02-22 1983-06-07 Smithkline Beckman Corporation Adamantyl containing peptides
NL8202626A (nl) * 1982-06-29 1984-01-16 Stichting Rega V Z W Derivaten van 9-(2-hydroxyethoxymethyl)guanine.

Also Published As

Publication number Publication date
US5110798A (en) 1992-05-05
EP0346460B1 (de) 1993-03-10
IT8723218A0 (it) 1987-12-24
JP2868560B2 (ja) 1999-03-10
DE3879191T2 (de) 1993-06-17
AU3052889A (en) 1989-07-19
DE3879191D1 (de) 1993-04-15
EP0346460A1 (de) 1989-12-20
IT1223604B (it) 1990-09-29
JPH02503006A (ja) 1990-09-20
WO1989005818A1 (en) 1989-06-29

Similar Documents

Publication Publication Date Title
HU9302007D0 (en) Method for producing pharmaceutical preparatives containing 2-|n-(2-amino-ethyl)-amino¨-acetic acid derivatives
ES545330A0 (es) Un procedimiento para preparar derivados de 1,3-difosfonato
DE68911159D1 (de) Pyrido[2,3-d]pyrimidinderivate.
ATE86630T1 (de) Purin-derivate mit pharmakologischer wirksamkeit.
HU9201575D0 (en) Pyrimidone derivatives and their analogues
ZA873721B (en) Substituted 6-hydroxymethyl-carbapenem antibiotics,a process for the preparation thereof,and the use thereof
KR880005927A (ko) 카복실산 아미드의 용도
EP0222283A3 (en) Amino-acid derivatives
DE3873812D1 (de) 3h-1,2,3-triazolo(4,5-d)pyrimidine.
NO902157L (no) Butensyrederivater for terapeutisk anvendelse.
ES2086528T3 (es) Nuevos compuestos biciclicos sustituidos con amino.
EP0193887A3 (en) Substituted o-sulfonyl-glycosyl amides, method for their preparation and their use as mediacments
DE3664564D1 (en) 4-amino-2-(imidazolidine-2-on-1-yl)-pyrimidine-5-carboxylic acid-(n-(3-trifluormethyl-phenyl)-amides)for antithrombotic prophylaxis and treatment and its use in the production of antithrombotic medicaments
DE3666223D1 (en) Anticonvulsant agents
DE3778642D1 (de) Therapeutikum zur behandlung von magengeschwueren.
ES8507476A1 (es) Un procedimiento para la preparacion de nuevos benzonitrilos
PH21982A (en) N-(3-triflouromethyl-phenyl)-n'-propargylpiperazine and method of use thereof
ES8106147A1 (es) Procedimiento para preparar un 1,2,4-triazol-3-tiol
NO890245L (no) Isoxazoler med nootrop aktivitet.
DE3167839D1 (en) Method for preparing n-(4-(((2,4-diamino-6-pteridinyl)-methyl)methylamino)benzoyl)glutamic acid
ES2039255T3 (es) Utilizacion de n-((1-etil-2-pirrolidinil)metil)-2-metoxi-5-sulfamoil-benzamida en el tratamiento de la esterilidad.
DE3674060D1 (de) Pharmacologisch aktive propionylanilide.
FR2455037A1 (fr) Medicament freinateur des activites hypophysaires
SU1783774A1 (ru) Натриевая соль n-(3-хлорбутен-2-ил)антраниловой кислоты, проявляющая противовоспалительную и анальгетическую активность
BE851997A (fr) Ergosine et ses sels d'addition d'acides physiologiquement acceptables

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee